Osteoporosis in chronic inflammatory disease: The role of malnutrition

Endocrine

Volumn 43, Issue 1, 2013, Pages 59-64

  Montalcini, Tiziana ^a   Romeo, Stefano ^a,b   Ferro, Yvelise ^a   Migliaccio, Valeria ^a   Gazzaruso, Carmine ^c,d   Pujia, Arturo ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Vascular and Endocrine Metabolic Diseases Unit and the Centre for Applied Clinical Research (CeRCA) Clinical Institute Beato Matteo   (Italy)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Anorexia; Cachexia; Inflammation; Malnutrition; Osteoporosis

Indexed keywords

ADIPONECTIN; CALCIUM; CYTOKINE; LEPTIN; MAGNESIUM; VITAMIN D;

ANOREXIA; CACHEXIA; CALCIUM HOMEOSTASIS; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; FRACTURE; FRAGILITY FRACTURE; HORMONE ACTION; HUMAN; MALNUTRITION; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION;

EID: 84872279922     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9813-x     Document Type: Review

References (90)

1. J.T. Lin, J.M. Lane, Osteoporosis: a review. Clin. Orthop. Relat. Res. 425, 126-134 (2004)
2. P. Sambrook, C. Cooper, Osteoporosis. Lancet 367, 2010-2018 (2006)
3. S. Khosla, B. Riggs, Pathophysiology of age-related bone loss and osteoporosis. Endocrinol. Metab. Clin. N. Am. 34, 1015-1030 (2005)
4. S. Khosla, B. Riggs, R. Robb, J. Camp, S. Achenbach, A. Oberg, P.A. Rouleau, L.J. Melton 3rd, Relationship of volumetric bone density and structural parameters at different skeletal sites to sex steroid levels in women. J. Clin. Endocrinol. Metab. 90, 5096-5103 (2005)
5. K. Walker, Bone recognizing and treating secondary osteoporosis. Nat. Rev. Rheumatol. 8, 480-492 (2012)
6. V.E. MacRae, S.C. Wong, C. Farquharson, S.F. Ahmed, Cytokine actions in growth disorders associated with pediatric chronic inflammatory diseases. Int. J. Mol. Med. 18, 1011-1018 (2006)
7. T. Larussa, E. Suraci, I. Nazionale, I. Leone, T. Montalcini, L. Abenavoli, M. Imeneo, A. Pujia, F. Luzza, No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. World J. Gastroenterol. 14(18), 1622-1627 (2012)
8. G.J. Tack, W.H. Verbeek, M.W. Schreurs, C.J. Mulder, The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat. Rev. Gastroenterol. Hepatol. 4, 204-213 (2010)
9. P. Georgiadou, S. Adamopoulos, Skeletal muscle abnormalities in chronic heart failure. Curr. Heart Fail. Rep. 9, 128-132 (2012)
10. T. Montalcini, V. Emanuele, R. Ceravolo, G. Gorgone, G. Sesti, F. Perticone, A. Pujia, Relation of low bone mineral density and carotid atherosclerosis in postmenopausal women. Am. J. Cardiol. 94, 266-269 (2004)
11. D.L. Broussard, J.H. Magnus, Coronary heart disease risk and bone mineral density among U.S. women and men. J. Womens Health 17, 479-490 (2008)
12. R. Varma, W.S. Aronow, Y. Basis, T. Singh, K. Kalapatapu, M.B. Weiss, A.L. Pucillo, C.E. Monsen, Relation of bone mineral density to frequency of coronary heart disease. Am. J. Cardiol. 101, 1103-1104 (2008)
13. E. Erbilen, S. Yazici, H. Ozhan, S. Bulur, S. Ordu, M. Yazici, Relationship between angiographically documented coronary artery disease and low bone mass in men. Circ. J. 7, 1095-1098 (2007)
14. M. Gossl, U.I. Modder, E.J. Atkinson, A. Lerman, S. Khosla, Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J. Am. Coll. Cardiol. 52, 1314-1325 (2008)
15. R. Ohmori, Y. Momiyama, H. Taniguchi, M. Kusuhara, H. Nakamura, F. Ohsuzu, Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 170, 333-337 (2003)
16. L. Graat-Verboom, M.A. Spruit, B.E. van den Borne, F.W. Smeenk, E.J. Martens, R. Lunde, E.F. Wouters, Correlates of osteoporosis in chronic obstructive pulmonary disease: an underestimated systemic component. Respir. Med. 103, 1143-1151 (2009)
17. G. Cascini, C. Falcone, C. Greco, B. Bertucci, S. Cipullo, O. Tamburrini, Whole-body magnetic resonance imaging for detecting bone metastases: comparison with bone scintigraphy. Radiol. Med. 113, 1157-1170 (2008)
18. K. Martensson, D. Chrysis, L. Savendahl, Interleukin-1 beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones. J. Bone Miner. Res. 19, 1805-1812 (2004)
19. V.E. MacRae, C. Farquharson, S.F. Ahmed, The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines. J. Endocrinol. 189, 319-328 (2006)
20. J.C. Tan, R. Rabkin, Suppressors of cytokine signaling in health and disease. Pediatr. Nephrol. 20, 567-575 (2005)
21. E. Choy, Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxf.) 5, 3-11 (2012)
22. A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535-559 (2008)
23. S. Ferrari-Lacraz, S. Ferrari, Do RANKL inhibitors (denosumab) affect inflammation and immunity? Osteoporos. Int. 22, 435-446 (2011)
24. M. Chabaud, J.M. Durand, N. Buchs, F. Fossiez, G. Page, L. Frappart et al., Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthr. Rheum. 42, 963-970 (1999)
25. C.K. Wong, C.Y. Ho, E.K. Li, C.W. Lam, Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9, 589-593 (2000)
26. K. Kurasawa, K. Hirose, H. Sano, H. Endo, H. Shinkai, Y. Nawata et al., Increased interleukin-17 production in patients with systemic sclerosis. Arthr. Rheum. 43, 2455-2463 (2000)
27. M.A. Lowes, T. Kikuchi, J. Fuentes-Duculan, I. Cardinale, L.C. Zaba, A.S. Haider et al., Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 128, 1207-1211 (2008)
28. A.M. Tyagi, K. Srivastava, M.N. Mansoori, R. Trivedi, N. Chattopadhyay, D. Singh, Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. PLoS ONE 7, e44552 (2012)
29. G. Schett, Effects of inflammatory and anti-inflammatory cytokines on the bone. Eur. J. Clin. Invest. 41, 1361-1366 (2011)
30. S. Koch, P. Nava, C. Addis, W. Kim, T.L. Denning, L. Li, C.A. Parkos, A. Nusrat, The Wnt antagonist Dkk1 regulates intestinal epithelial homeostasis and wound repair. Gastroenterology 141, 259-268 (2011)
31. R. Baron, G. Rawadi, Targeting the Wnt/β catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148, 2635-2643 (2007)
32. C.R. Plata-Salamán, Cytokines and feeding. Int. J. Obes. 25, S48-S52 (2001)
33. A. Inui, Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res. 59, 4493-4501 (1999)
34. J.M. Argiles, S. Busquets, F.J. Lopez-Soriano, The pivotal role of cytokines in muscle wasting during cancer. Int. J. Biochem. Cell Biol. 37, 1609-1619 (2005)
35. J.M. Argilés, S. Busquets, F.J. López-Soriano, Anti-inflammatory therapies in cancer cachexia. Eur. J. Pharmacol. 1, 81-86 (2011)
36. M.B. Reid, Y.P. Li, Tumor necrosis factor-alpha and muscle wasting: a cellular perspective. Respir. Res. 2, 269-272 (2001)
37. A. Laviano, M.M. Meguid, F. Rossi-Fanelli, Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol. 4, 686-694 (2003)
38. A. Tournadre, P. Miossec, Interleukin-17 in inflammatory myopathies. Curr. Rheumatol. Rep. 14, 252-256 (2012)
39. J. von Maltzahn, N.C. Chang, C.F. Bentzinger, M.A. Rudnicki, Wnt signaling in myogenesis. Trends Cell Biol. (2012)
40. R. Faggioni, K.R. Feingold, C. Grunfeld, Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J. 14, 2565-2571 (2001)
41. V. Sanna, A. Di Giacomo, A. La Cava, R.I. Lechler, S. Fontana, S. Zappacosta, G. Matarese, Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest. 111, 241-250 (2003)
42. M. Otero, R. Lago, F. Lago, F.F. Casanueva, C. Dieguez, J.J. Gómez-Reino, O. Gualillo, Leptin, from fat to inflammation: old questions and new insights. FEBS Lett. 579, 295-301 (2005)
43. H.S. Berner, S.P. Lyngstadaas, A. Spahr, M. Monjo, L. Thommesen, C.A. Drevon, U. Syversen, J.E. Reseland, Adiponectin and its receptors are expressed in bone-forming cells. Bone 35, 842-849 (2004)
44. C. Roux, A. Arabi, R. Porcher, P. Garnro, Serum leptin as a determinant of bone resorption in healthy postmenopausal women. Bone 33, 837-852 (2003)
45. J.M. Gimble, M.E. Nuttall, Bone and fat: old questions, new insights. Endocrine 23, 183-188 (2004)
46. G. Musso, Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block. Endocrine (2012). doi: 10.1007/s12020-012-9748-2
47. G.S. Kim, J.S. Hong, S.W. Kim, J.M. Koh, C.S. An, J.Y. Choi, S.L. Cheng, Leptin induces apoptosis via ERK/cPLA2/cytochrome c pathway in human bone marrow stromal cells. J. Biol. Chem. 13, 21920-21929 (2003)
48. H. Blain, A. Vuillemin, F. Guillemin, B. Hanesse, N. de Talance, B. Doucet, C. Jeandel, Serum leptin levels is a predictor of bone mineral density in postmenopausal women. J. Clin. Endocrinol. Metab. 87, 1030-1035 (2002)
49. A. Goulding, R.W. Taylor, Plasma leptin values in relation to bone mass and density to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif. Tissue Int. 63, 56-458 (1998)
50. M. Yamauchi, T. Sugimoto, T. Yamaguchi, D. Nakaoka, M. Kanzawa, S. Yano, R. Ozuru, T. Sugishita, K. Chihara, Plasma leptin concentrations are associated with bone mineral density and presence of vertebral fractures in postmenopausal women. Clin. Endocrinol. (Oxf.) 55, 341-347 (2001)
51. M.D. Kontogianni, U.G. Dafni, J.G. Routsias, F.N. Skopouli, Blood leptin and resistin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J. Bone Miner. Res. 19, 546-551 (2004)
52. F. Rauch, W.F. Blum, K. Klein, B. Allolio, E. Schonau, Does leptin have an effect on bone in adult women? Calcif. Tissue Int. 63, 453-455 (1998)
53. M. YIlmaz, I. Keles, G. AydIn, S. Orkun, M. Bayram, F.C. Sevinc, U. Kisa, I. Yetkin, Plasma leptin concentration in postmenopausal women with osteoporosis. Endocr. Res. 31, 133-138 (2005)
54. G. Sahin, G. Polat, S. Bagis, A. Milcan, O. Bagdatoglu, C. Erdogan, H. Camdeviren, Body composition, bone mineral density and circulating leptin levels in postmenopausal Turkish women. Rhematol. Int. 23, 87-91 (2003)
55. M. Shaarawy, A.F. Abassi, H. Hassan, M.E. Salem, Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis. Fertil. Steril. 79, 919-924 (2003)
56. P. Marie, F. Debias, M. Cohen-Solal, M.C. Vernejoul, New factors controlling bone remodeling. Joint Bone Spine 67, 150-156 (2000)
57. P. Xue, P. Gao, Y. Li, The association between metabolic syndrome and bone mineral density: a meta-analysis. Endocrine (2012). doi: 10.1007/s12020-012-9684-1
58. S. Pinto, A.G. Roseberry, H. Liu, S. Diano, M. Shanabrough, X. Cai, J.M. Friedman, T.L. Horvath, Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304, 110-115 (2004)
59. R.E. Hubbard, M.S. O'Mahony, B.L. Calver, K.W. Woodhouse, Nutrition, inflammation, and leptin levels in aging and frailty. J. Am. Geriatr. Soc. 56, 279-284 (2008)
60. E. Toussirot, D. Binda, C. Gueugnon, G. Dumoulin, Adiponectin in autoimmune diseases. Curr. Med. Chem. (2012). [Epub ahead of print]
61. K.E. Barbour, J.M. Zmuda, R. Boudreau, E.S. Strotmeyer, M.J. Horwitz, R.W. Evans, Health ABC Study et al., The effects of adiponectin and leptin on changes in bone mineral density. Osteoporos. Int. 23, 1699-1710 (2012)
62. K.E. Barbour, J.M. Zmuda, R. Boudreau, E.S. Strotmeyer, M.J. Horwitz, R.W. Evans et al., Adipokines and the risk of fracture in older adults. J. Bone Miner. Res. 26, 1568-1576 (2011)
63. E. Guillod-Maximin, A.F. Roy, C.M. Vacher, A. Aubourg, V. Bailleux, A. Lorsignol et al., Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons. J. Endocrinol. 200, 93-105 (2009)
64. T. Constans, Y. Bacq, J.F. Brechot, J.L. Guilmot, P. Choutet, F. Lamisse, Protein-energy malnutrition in elderly medical patients. J. Am. Geriatr. Soc. 40, 263-268 (1992)
65. J. Woo, Y.T. Mak, R. Swaminathan, Nutritional status of general medical patients: influence of age and disease. J. Nutr. Biochem. 2, 274-280 (1991)
66. R.C. Nelson, L.R. Franzi, Nutrition and aging. Med. Clin. N. Am. 73, 1531-1550 (1989)
67. J.P. McWhirter, C.R. Pennington, Incidence and recognition of malnutrition in hospital. Br. Med. J. 308, 945-948 (1994)
68. J.E. Morley, A.J. Silver, M. Fiatarone, A.D. Mooradian, Geriatric grand rounds: nutrition and the elderly. J. Am. Geriatr. Soc. 34, 823-832 (1986)
69. D.H. Sullivan, G.A. Patch, R.C. Walls, D.A. Lipschitz, Impact of nutrition status on morbidity and mortality in a select population of geriatric rehabilitation patients. Am. J. Clin. Nutr. 51, 749-758 (1990)
70. R.K. Chandra, The relation between immunology, nutrition and disease in elderly people. Age Ageing 19, 25-31 (1990)
71. M.A. Fiatarone, W.J. Evans, The etiology and reversibility of muscle dysfunction in the aged. J. Gerontol. 48, 77-83 (1993)
72. A.N. Galanos, C.F. Pieper, J.C. Cornoni-Huntley, C.W. Bales, G.G. Fillenbaum, Nutrition and function: is there a relationship between body mass index and the functional capabilities of community-dwelling elderly? J. Am. Geriatr. Soc. 42, 368-373 (1994)
73. J. Lopes, D.M. Russell, J. Whitwell, K.N. Jeejeebhoy, Skeletal muscle function in malnutrition. Am. J. Clin. Nutr. 36, 602-610 (1982)
74. M.J. Ronis, K. Mercer, J.R. Chen, Effects of nutrition and alcohol consumption on bone loss. Curr. Osteoporos. Rep. 9, 53-59 (2011)
75. J.P. Bonjour, Calcium and phosphate: a duet of ions playing for bone health. J. Am. Coll. Nutr. 30, 438S-448S (2011)
76. P. Bordelon, M.V. Ghetu, R. Langan, Recognition and management of vitamin D deficiency. Am. Fam. Physician 80, 841-846 (2009)
77. S. Boonen, H.A. Bischoff-Ferrari, C. Cooper, P. Lips, O. Ljunggren, P.J. Meunier, J.Y. Reginster, Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcif. Tissue Int. 78, 257-270 (2006)
78. G. Isaia, R. Giorgino, G.B. Rini, M. Bevilacqua, D. Maugeri, S. Adami, Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos. Int. 14, 577-582 (2003)
79. O. Sahota, M.K. Mundey, P. San, I.M. Godber, D.J. Hosking, Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos. Int. 17, 1013-1021 (2006)
80. J. Aaseth, G. Boivin, O. Andersen, Osteoporosis and trace elements - an overview. J. Trace Elem. Med. Biol. 26, 149-152 (2012)
81. M.A. Daamen, J.M. Schols, T. Jaarsma, J.P. Hamers, Prevalence of heart failure in nursing homes: a systematic literature review. Scand. J. Caring Sci. 24, 202-208 (2010)
82. J.M. Chandler, S.I. Zimmerman, C.J. Girman, A.R. Martin, W. Hawkes, J.R. Hebel, P.D. Sloane, L. Holder, J. Magaziner, Low bone mineral density and risk of fracture in white female nursing home residents. J. Am. Med. Assoc. 30(284), 972-977 (2000)
83. R. Thibault, C. Pichard, The evaluation of body composition: a useful tool for clinical practice. Ann. Nutr. Metab. 60, 6-16 (2012)
84. A.D. Anastasilakis, K.A. Toulis, S.A. Polyzos, C.D. Anastasilakis, P. Makras, Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab. Ther. Clin. Risk Manag. 8, 295-306 (2012)
85. G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41, 58-69 (2012)
86. C. Roggia, Y. Gao, S. Cenci, M.N. Weitzmann, G. Toraldo, G. Isaia, R. Pacifici, Upregulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc. Natl Acad. Sci. U. S. A. 98, 13960-13965 (2001)
87. R. Kimble, S. Bain, R. Pacifici, The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J. Bone Miner. Res. 12, 935-941 (1997)
88. K. Sinningen, E. Tsourdi, M. Rauner, T.D. Rachner, C. Hamann, L.C. Hofbauer, Skeletal and extraskeletal actions of denosumab. Endocrine 42, 52-62 (2012)
89. B.F. Ricciardi, J. Paul, A. Kim, L.A. Russell, J.M. Lane, Osteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease. Osteoporos. Int. (2012). doi: 10.1007/s00198-012-2113-8
90. S. Wei, H. Kitaura, P. Zhou, F.P. Ross, S.L. Teitelbaum, IL-1 mediates TNF-induced osteoclastogenesis. J. Clin. Invest. 115, 282-290 (2005)